These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13867794)

  • 1. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806).
    BERGSAGEL DE; SPRAGUE CC; AUSTIN C; GRIFFITH KM
    Cancer Chemother Rep; 1962 Aug; 21():87-99. PubMed ID: 13867794
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma.
    BERGSAGEL DE
    Cancer Chemother Rep; 1962 Feb; 16():261-66. PubMed ID: 13867796
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. III. AB-100 (NSC-37095).
    BROWN CL; BERGSAGEL DE; LEVIN WC
    Cancer Chemother Rep; 1962 Aug; 21():81-5. PubMed ID: 13873596
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. V. 1-Aminocyclopentanecarboxylic acid (NSC-1026).
    BERGSAGEL DE; ROSS SW; BAKER DT
    Cancer Chemother Rep; 1962 Aug; 21():101-6. PubMed ID: 13867792
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. II. Mitomycin C (NSC-26980).
    BERGSAGEL DE; ROSS SW; DAVIS P
    Cancer Chemother Rep; 1962 Aug; 21():75-80. PubMed ID: 13867793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experience with the use of sarcolysin in multiple myeloma].
    ALEKSEEV GA; PETROV KIa
    Probl Gematol Pereliv Krovi; 1961 Dec; 6():3-10. PubMed ID: 13860267
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. VI. Metasarcolysin.
    AUSTIN C; BERGSAGEL DE; SPRAGUE CC
    Cancer Chemother Rep; 1962 Aug; 21():107-12. PubMed ID: 13863325
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. I. Plan of study.
    BERGSAGEL DE; SPRAGUE CC; ROSS SW
    Cancer Chemother Rep; 1962 Aug; 21():69-74. PubMed ID: 13867795
    [No Abstract]   [Full Text] [Related]  

  • 9. [3 Cases of myelomic diseases treated with sarcolysin].
    BELIAKOVA MM
    Sov Med; 1960 Feb; 24():62-5. PubMed ID: 13798452
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative study of optimal medical care with and without azaserine in multiple myeloma.
    HOLLAND JF
    Clin Pharmacol Ther; 1961; 2():22-8. PubMed ID: 13715278
    [No Abstract]   [Full Text] [Related]  

  • 11. [A case of successful treatment with sarcolysin of a patient with myeloma].
    BAISOGOLOV GD; DOSHCHENKO VN; CHIZH AS
    Probl Gematol Pereliv Krovi; 1961 Aug; 6():51-4. PubMed ID: 13864079
    [No Abstract]   [Full Text] [Related]  

  • 12. [A contribution to the therapy of plasmocytoma].
    PETRIDES P; MONCKE C
    Verh Dtsch Ges Inn Med; 1959; 65():211-4. PubMed ID: 14432305
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of multiple myeloma with I-aminocyclopentanecarboxylic acid (NSC-1026).
    KRANT MJ; ISZARD DM; ABADI A; CAREY RW
    Cancer Chemother Rep; 1962 Sep; 22():59-64. PubMed ID: 14459328
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the treatment of myeloma].
    GRIGOR'IANTS AN; VOLKOVA MA
    Sov Med; 1962 Jul; 26():20-3. PubMed ID: 13901909
    [No Abstract]   [Full Text] [Related]  

  • 15. [Considerations on the therapy of plasmocytoma (on the basis of 6 personal cases].
    CATTANEO I; ESPOSITO S
    Haematologica; 1959; 44():713-34. PubMed ID: 13808453
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the cytostatic therapy of plasmocytoma].
    FASS H
    Med Monatsschr; 1962 Jun; 16():389-93. PubMed ID: 13891742
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical remission in a case of plasmacytoma obtained with the therapeutic association of dexamethazone and triethylenethhiophosphoramide].
    AZZENA D; BELLOTTI R; ASTENGO F
    Clin Ter; 1959 Oct; 17():370-81. PubMed ID: 13795426
    [No Abstract]   [Full Text] [Related]  

  • 18. L-PHENYLALANINE MUSTARD (NSC-8806) IN UNCOMMON MALIGNANT DISEASE IN CHILDREN.
    GRINBERG R; NEMOTO T; DAO TL
    Cancer Chemother Rep; 1965 Apr; 45():63-7. PubMed ID: 14328051
    [No Abstract]   [Full Text] [Related]  

  • 19. THE BIOCHEMICAL MECHANISM OF ACTION OF L-PHENYLALANINE MUSTARD. I. DISTRIBUTION OF L-PHENYLALANINE MUSTARD-H3 IN TUMOR-BEARING RATS.
    MILNER AN; KLATT O; YOUNG SE; STEHLIN JS
    Cancer Res; 1965 Feb; 25():259-64. PubMed ID: 14264059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of multiple myeloma].
    GONZALEZ BOSCH R
    Dia Med; 1959 Aug; 31():1524-6. PubMed ID: 13850977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.